On the public citation graph
Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action
0 signed · 291 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/1521-4141(200001)30:1<1::aid-immu1>3.0.co;2-#openalex-snapshot
In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies
inferredcites →https://doi.org/10.1002/amp2.10060openalex-snapshot
Rapid development and deployment of high‐volume vaccines for pandemic response
inferredcites →https://doi.org/10.1002/eji.1830230749openalex-snapshot
Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA
inferredcites →https://doi.org/10.1002/eji.200940160openalex-snapshot
Pyroptosis – a cell death modality of its kind?
inferredcites →https://doi.org/10.1002/iub.1625openalex-snapshot
RNA sensors of the innate immune system and their detection of pathogens
inferredcites →https://doi.org/10.1006/viro.1997.8878openalex-snapshot
Replicon-Helper Systems from Attenuated Venezuelan Equine Encephalitis Virus: Expression of Heterologous Genesin Vitroand Immunization against Heterologous Pathogensin Vivo
inferredcites →https://doi.org/10.1007/82_2020_217openalex-snapshot
Formulation and Delivery Technologies for mRNA Vaccines
inferredcites →https://doi.org/10.1007/978-1-4939-3389-1_22openalex-snapshot
Alphavirus-Based Vaccines
inferredcites →https://doi.org/10.1007/978-1-4939-6481-9_1openalex-snapshot
Introduction to RNA Vaccines
inferredcites →https://doi.org/10.1007/978-1-4939-6869-5_13openalex-snapshot
Alphavirus-Based Vaccines
inferredcites →https://doi.org/10.1007/978-1-62703-260-5_3openalex-snapshot
HPLC Purification of In Vitro Transcribed Long RNA
inferredcites →https://doi.org/10.1007/s00018-018-2935-4openalex-snapshot
mRNA as novel technology for passive immunotherapy
inferredcites →https://doi.org/10.1007/s00262-018-2276-zopenalex-snapshot
An alphavirus-based therapeutic cancer vaccine: from design to clinical trial
inferredcites →https://doi.org/10.1016/0042-6822(77)90471-8openalex-snapshot
Sindbis virus messenger RNA: the 5′-termini and methylated residues of 26 and 42 S RNA
inferredcites →https://doi.org/10.1016/0264-410x(94)90074-4openalex-snapshot
Self-replicating Semliki Forest virus RNA as recombinant vaccine
inferredcites →https://doi.org/10.1016/bs.adgen.2014.10.005openalex-snapshot
Self-Amplifying mRNA Vaccines
inferredcites →https://doi.org/10.1016/j.antiviral.2019.01.015openalex-snapshot
New World alphavirus protein interactomes from a therapeutic perspective
inferredcites →https://doi.org/10.1016/j.biomaterials.2018.01.010openalex-snapshot
Unifying in vitro and in vivo IVT mRNA expression discrepancies in skeletal muscle via mechanotransduction
inferredcites →https://doi.org/10.1016/j.cell.2006.02.015openalex-snapshot
Pathogen Recognition and Innate Immunity
inferredcites →https://doi.org/10.1016/j.cell.2009.01.019openalex-snapshot
The Many Pathways of RNA Degradation
inferredcites →https://doi.org/10.1016/j.coi.2017.03.006openalex-snapshot
Plasma cell and memory B cell differentiation from the germinal center
inferredcites →https://doi.org/10.1016/j.coi.2017.06.008openalex-snapshot
Germinal center enhancement by extended antigen availability
inferredcites →https://doi.org/10.1016/j.coviro.2017.02.004openalex-snapshot
Alphaviruses suppress host immunity by preventing myeloid cell replication and antagonizing innate immune responses
inferredcites →https://doi.org/10.1016/j.cytogfr.2014.05.002openalex-snapshot
IFIT1: A dual sensor and effector molecule that detects non-2′-O methylated viral RNA and inhibits its translation
inferredcites →https://doi.org/10.1016/j.immuni.2006.08.014openalex-snapshot
Complex Modulation of Cell Type-Specific Signaling in Response to Type I Interferons
inferredcites →https://doi.org/10.1016/j.immuni.2010.10.002openalex-snapshot
Vaccine Adjuvants: Putting Innate Immunity to Work
inferredcites →https://doi.org/10.1016/j.immuni.2017.05.007openalex-snapshot
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
inferredcites →https://doi.org/10.1016/j.jconrel.2013.01.033openalex-snapshot
Innate immune response and programmed cell death following carrier-mediated delivery of unmodified mRNA to respiratory cells
inferredcites →https://doi.org/10.1016/j.jconrel.2017.09.018openalex-snapshot
Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure
inferredcites →https://doi.org/10.1016/j.jconrel.2019.04.043openalex-snapshot
Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA
inferredcites →https://doi.org/10.1016/j.jconrel.2020.11.033openalex-snapshot
Effect of complexing lipids on cellular uptake and expression of messenger RNA in human skin explants
inferredcites →https://doi.org/10.1016/j.molmed.2017.01.006openalex-snapshot
Type I Interferons Modulate CD8 + T Cell Immunity to mRNA Vaccines
inferredcites →https://doi.org/10.1016/j.nano.2015.11.001openalex-snapshot
Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines
inferredcites →https://doi.org/10.1016/j.omtm.2018.10.010openalex-snapshot
Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA
inferredcites →https://doi.org/10.1016/j.omtm.2020.06.011openalex-snapshot
Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection
inferredcites →https://doi.org/10.1016/j.omtn.2017.11.005openalex-snapshot
Rapid, Single-Cell Analysis and Discovery of Vectored mRNA Transfection In Vivo with a loxP-Flanked tdTomato Reporter Mouse
inferredcites →https://doi.org/10.1016/j.omtn.2018.04.019openalex-snapshot
Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids
inferredcites →https://doi.org/10.1016/j.omtn.2018.11.002openalex-snapshot
Proximity Ligation Assays for In Situ Detection of Innate Immune Activation: Focus on In Vitro-Transcribed mRNA
inferredcites →https://doi.org/10.1016/j.omtn.2019.02.018openalex-snapshot
A Facile Method for the Removal of dsRNA Contaminant from In Vitro-Transcribed mRNA
inferredcites →https://doi.org/10.1016/j.omtn.2019.07.014openalex-snapshot
Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine
inferredcites →https://doi.org/10.1016/j.omtn.2019.08.001openalex-snapshot
Expression Kinetics and Innate Immune Response after Electroporation and LNP-Mediated Delivery of a Self-Amplifying mRNA in the Skin
inferredcites →https://doi.org/10.1016/j.smim.2013.05.001openalex-snapshot
RNA: The new revolution in nucleic acid vaccines
inferredcites →https://doi.org/10.1016/j.smim.2017.08.015openalex-snapshot
Delivering the right message: Challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics—An innate immune system standpoint
inferredcites →https://doi.org/10.1016/j.tim.2012.02.001openalex-snapshot
Regulation of stress granules in virus systems
inferredcites →https://doi.org/10.1016/j.vaccine.2009.09.135openalex-snapshot
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers
inferredcites →https://doi.org/10.1016/j.vaccine.2012.04.030openalex-snapshot
Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles
inferredcites →https://doi.org/10.1016/j.vaccine.2015.11.062openalex-snapshot
Prime-boost vaccine strategy against viral infections: Mechanisms and benefits
inferredcites →https://doi.org/10.1016/j.vaccine.2016.11.040openalex-snapshot
Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens
inferredcites →https://doi.org/10.1016/j.vaccine.2019.04.028openalex-snapshot
Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines
inferredcites →https://doi.org/10.1016/j.vaccine.2019.04.074openalex-snapshot
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
inferredcites →https://doi.org/10.1016/j.vaccine.2020.12.070openalex-snapshot
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial
inferredcites →https://doi.org/10.1016/j.virol.2008.10.030openalex-snapshot
Characterization of purified Sindbis virus nsP4 RNA-dependent RNA polymerase activity in vitro
inferredcites →https://doi.org/10.1016/j.virol.2009.02.027openalex-snapshot
The 5′UTR-specific mutation in VEEV TC-83 genome has a strong effect on RNA replication and subgenomic RNA synthesis, but not on translation of the encoded proteins
inferredcites →https://doi.org/10.1016/j.virol.2013.07.021openalex-snapshot
Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity
inferredcites →https://doi.org/10.1016/j.virol.2015.04.023openalex-snapshot
Control of alphavirus-based gene expression using engineered riboswitches
inferredcites →https://doi.org/10.1016/j.virol.2016.06.005openalex-snapshot
Host translation shutoff mediated by non-structural protein 2 is a critical factor in the antiviral state resistance of Venezuelan equine encephalitis virus
inferredcites →https://doi.org/10.1016/j.virusres.2015.01.016openalex-snapshot
The 5′ and 3′ ends of alphavirus RNAs – Non-coding is not non-functional
inferredcites →https://doi.org/10.1016/j.virusres.2017.01.007openalex-snapshot
Alphavirus polymerase and RNA replication
inferredcites →https://doi.org/10.1016/j.xphs.2020.12.006openalex-snapshot
Addressing the Cold Reality of mRNA Vaccine Stability
inferredcites →https://doi.org/10.1016/j.ymthe.2017.03.035openalex-snapshot
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
inferredcites →https://doi.org/10.1016/j.ymthe.2017.08.006openalex-snapshot
Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
inferredcites →https://doi.org/10.1016/j.ymthe.2017.11.017openalex-snapshot
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
inferredcites →https://doi.org/10.1016/j.ymthe.2018.07.010openalex-snapshot
A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika
inferredcites →https://doi.org/10.1016/j.ymthe.2018.11.018openalex-snapshot
mRNA-Based Protein Replacement Therapy for the Heart
inferredcites →https://doi.org/10.1016/j.ymthe.2018.12.009openalex-snapshot
mRNA-Based Genetic Reprogramming
inferredcites →https://doi.org/10.1016/j.ymthe.2018.12.012openalex-snapshot
Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases
inferredcites →https://doi.org/10.1016/j.ymthe.2018.12.013openalex-snapshot
Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice
inferredcites →https://doi.org/10.1016/j.ymthe.2019.01.014openalex-snapshot
Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9
inferredcites →https://doi.org/10.1016/j.ymthe.2019.01.020openalex-snapshot
mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
inferredcites →https://doi.org/10.1016/j.ymthe.2019.02.012openalex-snapshot
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
inferredcites →https://doi.org/10.1016/j.ymthe.2019.08.007openalex-snapshot
Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles
inferredcites →https://doi.org/10.1016/j.ymthe.2019.09.009openalex-snapshot
A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity
inferredcites →https://doi.org/10.1016/j.ymthe.2020.11.010openalex-snapshot
In Vivo Validation of a Reversible Small Molecule-Based Switch for Synthetic Self-Amplifying mRNA Regulation
inferredcites →https://doi.org/10.1016/j.ymthe.2020.11.011openalex-snapshot
Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA
inferredcites →https://doi.org/10.1016/j.yrtph.2020.104648openalex-snapshot
Nonclinical safety assessment of repeated administration and biodistribution of a novel rabies self-amplifying mRNA vaccine in rats
inferredcites →https://doi.org/10.1016/s0005-2736(02)00721-6openalex-snapshot
Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins
inferredcites →https://doi.org/10.1016/s0014-5793(99)00321-xopenalex-snapshot
RNA helicase activity of Semliki Forest virus replicase protein NSP2
inferredcites →https://doi.org/10.1016/s0140-6736(17)31665-3openalex-snapshot
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
inferredcites →https://doi.org/10.1016/s1525-0016(02)00056-4openalex-snapshot
Novel semliki forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression
inferredcites →https://doi.org/10.1017/s135583820101010xopenalex-snapshot
Cis-acting RNA elements at the 5′ end of Sindbis virus genome RNA regulate minus- and plus-strand RNA synthesis
inferredcites →https://doi.org/10.1021/acs.biomac.0c00445openalex-snapshot
Mannosylated Poly(ethylene imine) Copolymers Enhance saRNA Uptake and Expression in Human Skin Explants
inferredcites →https://doi.org/10.1021/acs.molpharmaceut.7b00722openalex-snapshot
Comparison of the Expression Kinetics and Immunostimulatory Activity of Replicating mRNA, Nonreplicating mRNA, and pDNA after Intradermal Electroporation in Pigs
inferredcites →https://doi.org/10.1021/acs.molpharmaceut.8b00370openalex-snapshot
Monitoring Translation Activity of mRNA-Loaded Nanoparticles in Mice
inferredcites →https://doi.org/10.1021/acsinfecdis.9b00084openalex-snapshot
Mannosylation of LNP Results in Improved Potency for Self-Amplifying RNA (SAM) Vaccines
inferredcites →https://doi.org/10.1021/acsnano.0c00326openalex-snapshot
Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer
inferredcites →https://doi.org/10.1021/acsnano.8b00966openalex-snapshot
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety
inferredcites →https://doi.org/10.1021/acsnano.9b01774openalex-snapshot
The Skin You Are In: Design-of-Experiments Optimization of Lipid Nanoparticle Self-Amplifying RNA Formulations in Human Skin Explants
inferredcites →https://doi.org/10.1021/mp400190zopenalex-snapshot
RNA Replicon Delivery via Lipid-Complexed PRINT Protein Particles
inferredcites →https://doi.org/10.1038/4031openalex-snapshot
In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model
inferredcites →https://doi.org/10.1038/cmi.2012.61openalex-snapshot
TLR signaling in B-cell development and activation
inferredcites →https://doi.org/10.1038/d41586-021-00019-wopenalex-snapshot
How COVID unlocked the power of RNA vaccines
inferredcites →https://doi.org/10.1038/emi.2013.54openalex-snapshot
Rapidly produced SAM ® vaccine against H7N9 influenza is immunogenic in mice
inferredcites →https://doi.org/10.1038/mt.2011.294openalex-snapshot
Action and Reaction: The Biological Response to siRNA and Its Delivery Vehicles
inferredcites →https://doi.org/10.1038/mt.2012.202openalex-snapshot
Type I IFN Counteracts the Induction of Antigen-Specific Immune Responses by Lipid-Based Delivery of mRNA Vaccines
inferredcites →https://doi.org/10.1038/mt.2014.133openalex-snapshot
A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines
inferredcites →https://doi.org/10.1038/mt.2016.161openalex-snapshot
Type I Interferons Interfere with the Capacity of mRNA Lipoplex Vaccines to Elicit Cytolytic T Cell Responses
inferredcites →https://doi.org/10.1038/mtna.2014.24openalex-snapshot
Self-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In Vivo
inferredcites →https://doi.org/10.1038/nature04734openalex-snapshot
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
inferredcites →https://doi.org/10.1038/nbt.3301openalex-snapshot
Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery
inferredcites →https://doi.org/10.1038/nbt1081openalex-snapshot
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
inferredcites →https://doi.org/10.1038/nbt1291-1356openalex-snapshot
A New Generation of Animal Cell Expression Vectors Based on the Semliki Forest Virus Replicon
inferredcites →https://doi.org/10.1038/nrd.2018.132openalex-snapshot
An RNA toolbox for cancer immunotherapy
inferredcites →https://doi.org/10.1038/nrd2742openalex-snapshot
Knocking down barriers: advances in siRNA delivery
inferredcites →https://doi.org/10.1038/nrd4278openalex-snapshot
mRNA-based therapeutics — developing a new class of drugs
inferredcites →https://doi.org/10.1038/nri3344openalex-snapshot
The broad-spectrum antiviral functions of IFIT and IFITM proteins
inferredcites →https://doi.org/10.1038/s41434-019-0095-2openalex-snapshot
Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA
inferredcites →https://doi.org/10.1038/s41434-020-00204-yopenalex-snapshot
Self-amplifying RNA vaccines for infectious diseases
inferredcites →https://doi.org/10.1038/s41467-018-05041-7openalex-snapshot
Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection
inferredcites →https://doi.org/10.1038/s41467-020-17409-9openalex-snapshot
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice
inferredcites →https://doi.org/10.1038/s41541-017-0032-6openalex-snapshot
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines
inferredcites →https://doi.org/10.1038/s41551-019-0378-3openalex-snapshot
Visualization of early events in mRNA vaccine delivery in non-human primates via PET–CT and near-infrared imaging
inferredcites →https://doi.org/10.1038/s41564-019-0421-xopenalex-snapshot
Decoding type I and III interferon signalling during viral infection
inferredcites →https://doi.org/10.1038/s41586-020-2639-4openalex-snapshot
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
inferredcites →https://doi.org/10.1038/s41586-020-2814-7openalex-snapshot
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
inferredcites →https://doi.org/10.1038/s41589-018-0146-9openalex-snapshot
Small-molecule-based regulation of RNA-delivered circuits in mammalian cells
inferredcites →https://doi.org/10.1038/s41598-017-00193-wopenalex-snapshot
An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model
inferredcites →https://doi.org/10.1038/s41598-018-26281-zopenalex-snapshot
Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity
inferredcites →https://doi.org/10.1038/s41598-018-30784-0openalex-snapshot
Characterization of induced tissue-specific stem cells from pancreas by a synthetic self-replicative RNA
inferredcites →https://doi.org/10.1038/s41598-019-43422-0openalex-snapshot
In vitro evolution of enhanced RNA replicons for immunotherapy
inferredcites →https://doi.org/10.1038/sj.gt.3302620openalex-snapshot
Biology and application of alphaviruses in gene therapy
inferredcites →https://doi.org/10.1046/j.1432-1327.2001.02273.xopenalex-snapshot
Mechanism of activation of the double‐stranded‐RNA‐dependent protein kinase, PKR
inferredcites →https://doi.org/10.1053/j.gastro.2006.10.032openalex-snapshot
A Cell-Based, High-Throughput Screen for Small Molecule Regulators of Hepatitis C Virus Replication
inferredcites →https://doi.org/10.1056/nejmc2032195openalex-snapshot
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination
inferredcites →https://doi.org/10.1056/nejmoa2022483openalex-snapshot
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
inferredcites →https://doi.org/10.1056/nejmoa2027906openalex-snapshot
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
inferredcites →https://doi.org/10.1056/nejmoa2028436openalex-snapshot
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
inferredcites →https://doi.org/10.1056/nejmoa2034577openalex-snapshot
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
inferredcites →https://doi.org/10.1073/pnas.111163898openalex-snapshot
Biologic consequences of Stat1-independent IFN signaling
inferredcites →https://doi.org/10.1073/pnas.1209367109openalex-snapshot
Nonviral delivery of self-amplifying RNA vaccines
inferredcites →https://doi.org/10.1073/pnas.1401662111openalex-snapshot
Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection
inferredcites →https://doi.org/10.1073/pnas.1600299113openalex-snapshot
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
inferredcites →https://doi.org/10.1073/pnas.1606050113openalex-snapshot
Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
inferredcites →https://doi.org/10.1073/pnas.1712377114openalex-snapshot
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
inferredcites →https://doi.org/10.1073/pnas.1908052116openalex-snapshot
mRNA structure regulates protein expression through changes in functional half-life
inferredcites →https://doi.org/10.1073/pnas.92.2.507openalex-snapshot
Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP.
inferredcites →https://doi.org/10.1074/jbc.270.11.6298openalex-snapshot
Self-coded 3′-Extension of Run-off Transcripts Produces Aberrant Products during in Vitro Transcription with T7 RNA Polymerase
inferredcites →https://doi.org/10.1074/jbc.m307481200openalex-snapshot
Regulation of the Sequential Processing of Semliki Forest Virus Replicase Polyprotein
inferredcites →https://doi.org/10.1080/14760584.2019.1640117openalex-snapshot
Novel prime-boost vaccine strategies against HIV-1
inferredcites →https://doi.org/10.1080/21645515.2016.1227900openalex-snapshot
Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood
inferredcites →https://doi.org/10.1084/jem.20080091openalex-snapshot
Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid–inducible gene-I and melanoma differentiation–associated gene 5
inferredcites →https://doi.org/10.1084/jem.20090851openalex-snapshot
Type I IFN controls chikungunya virus via its action on nonhematopoietic cells
inferredcites →https://doi.org/10.1086/319857openalex-snapshot
Self‐Replicative RNA Vaccines Elicit Protection against Influenza A Virus, Respiratory Syncytial Virus, and a Tickborne Encephalitis Virus
inferredcites →https://doi.org/10.1089/hgtb.2016.039openalex-snapshot
Effects of Self-Complementarity, Codon Optimization, Transgene, and Dose on Liver Transduction with AAV8
inferredcites →https://doi.org/10.1089/hum.2017.121openalex-snapshot
Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins
inferredcites →https://doi.org/10.1089/hum.2018.145openalex-snapshot
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell Response
inferredcites →https://doi.org/10.1089/jir.2010.0120openalex-snapshot
New Insights into the Role of RNase L in Innate Immunity
inferredcites →https://doi.org/10.1089/nat.2017.0697openalex-snapshot
Leveraging Rational Protein Engineering to Improve mRNA Therapeutics
inferredcites →https://doi.org/10.1093/infdis/jiu522openalex-snapshot
Potent Immune Responses in Rhesus Macaques Induced by Nonviral Delivery of a Self-amplifying RNA Vaccine Expressing HIV Type 1 Envelope With a Cationic Nanoemulsion
inferredcites →https://doi.org/10.1093/nar/12.12.5123openalex-snapshot
Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals
inferredcites →https://doi.org/10.1093/nar/15.21.8783openalex-snapshot
Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates
inferredcites →https://doi.org/10.1093/nar/23.9.1495openalex-snapshot
A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expressionin vivo
inferredcites →https://doi.org/10.1093/nar/gkp059openalex-snapshot
The regulatory domain of the RIG-I family ATPase LGP2 senses double-stranded RNA
inferredcites →https://doi.org/10.1093/nar/gkr695openalex-snapshot
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
inferredcites →https://doi.org/10.1093/nar/gkt1321openalex-snapshot
Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5′-terminal regions of cap0-, cap1- and 5′ppp- mRNAs
inferredcites →https://doi.org/10.1093/nar/gkx290openalex-snapshot
Characterizing exogenous mRNA delivery, trafficking, cytoplasmic release and RNA–protein correlations at the level of single cells
inferredcites →https://doi.org/10.1099/jgv.0.000249openalex-snapshot
Alphavirus RNA synthesis and non-structural protein functions
inferredcites →https://doi.org/10.1099/jgv.0.000448openalex-snapshot
Ability of minus strands and modified plus strands to act as templates in Semliki Forest virus RNA replication
inferredcites →https://doi.org/10.1099/vir.0.071845-0openalex-snapshot
Chikungunya virus non-structural protein 2-mediated host shut-off disables the unfolded protein response
inferredcites →https://doi.org/10.1101/2020.05.28.121640openalex-snapshot
Single-dose replicating RNA vaccine induces neutralizing antibodies against SARS-CoV-2 in nonhuman primates
inferredcites →https://doi.org/10.1111/imm.12505openalex-snapshot
CD 8 T‐cell priming upon mRNA vaccination is restricted to bone‐marrow‐derived antigen‐presenting cells and may involve antigen transfer from myocytes
inferredcites →https://doi.org/10.1111/imr.12512openalex-snapshot
Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem
inferredcites →https://doi.org/10.1111/j.0105-2896.2004.00139.xopenalex-snapshot
Cancer immunotherapy with mRNA‐transfected dendritic cells
inferredcites →https://doi.org/10.1111/j.1600-065x.2008.00670.xopenalex-snapshot
Host responses to alphavirus infection
inferredcites →https://doi.org/10.1126/sciadv.aaz6893openalex-snapshot
Impact of mRNA chemistry and manufacturing process on innate immune activation
inferredcites →https://doi.org/10.1126/sciadv.aba5068openalex-snapshot
Development of a potent Zika virus vaccine using self-amplifying messenger RNA
inferredcites →https://doi.org/10.1126/sciadv.abb2154openalex-snapshot
CD8 + T cells mediate protection against Zika virus induced by an NS3-based vaccine
inferredcites →https://doi.org/10.1126/science.1132505openalex-snapshot
5'-Triphosphate RNA Is the Ligand for RIG-I
inferredcites →https://doi.org/10.1126/science.1235208openalex-snapshot
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
inferredcites →https://doi.org/10.1126/science.1248465openalex-snapshot
A Viral RNA Structural Element Alters Host Recognition of Nonself RNA
inferredcites →https://doi.org/10.1126/science.1690918openalex-snapshot
Direct Gene Transfer into Mouse Muscle in Vivo
inferredcites →https://doi.org/10.1126/science.2922607openalex-snapshot
Sindbis Virus: An Efficient, Broad Host Range Vector for Gene Expression in Animal Cells
inferredcites →https://doi.org/10.1126/science.6272391openalex-snapshot
Cloned Poliovirus Complementary DNA Is Infectious in Mammalian Cells
inferredcites →https://doi.org/10.1126/sciimmunol.aah3565openalex-snapshot
Type I interferon suppresses virus-specific B cell responses by modulating CD8 + T cell differentiation
inferredcites →https://doi.org/10.1126/sciimmunol.aah6789openalex-snapshot
Inflammatory monocytes hinder antiviral B cell responses
inferredcites →https://doi.org/10.1126/sciimmunol.aah6817openalex-snapshot
Interferon-driven deletion of antiviral B cells at the onset of chronic infection
inferredcites →https://doi.org/10.1126/sciimmunol.aaj1836openalex-snapshot
Interfer’n with antibody responses
inferredcites →https://doi.org/10.1126/scitranslmed.3000799openalex-snapshot
Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine Design
inferredcites →https://doi.org/10.1126/scitranslmed.abc9396openalex-snapshot
An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates
inferredcites →https://doi.org/10.1128/cvi.00031-12openalex-snapshot
Lack of Interference with Immunogenicity of a Chimeric Alphavirus Replicon Particle-Based Influenza Vaccine by Preexisting Antivector Immunity
inferredcites →https://doi.org/10.1128/cvi.00258-12openalex-snapshot
Phase I Safety and Immunogenicity Evaluations of an Alphavirus Replicon HIV-1 Subtype C gag Vaccine in Healthy HIV-1-Uninfected Adults
inferredcites →https://doi.org/10.1128/jvi.00085-11openalex-snapshot
Assembly of Alphavirus Replication Complexes from RNA and Protein Components in a Novel trans -Replication System in Mammalian Cells
inferredcites →https://doi.org/10.1128/jvi.00152-18openalex-snapshot
A Chikungunya Virus trans -Replicase System Reveals the Importance of Delayed Nonstructural Polyprotein Processing for Efficient Replication Complex Formation in Mosquito Cells
inferredcites →https://doi.org/10.1128/jvi.00477-10openalex-snapshot
Phosphatidylinositol 3-Kinase-, Actin-, and Microtubule-Dependent Transport of Semliki Forest Virus Replication Complexes from the Plasma Membrane to Modified Lysosomes
inferredcites →https://doi.org/10.1128/jvi.00586-09openalex-snapshot
Structural and Functional Elements of the Promoter Encoded by the 5′ Untranslated Region of the Venezuelan Equine Encephalitis Virus Genome
inferredcites →https://doi.org/10.1128/jvi.00884-13openalex-snapshot
The C-Terminal Domain of Chikungunya Virus nsP2 Independently Governs Viral RNA Replication, Cytopathicity, and Inhibition of Interferon Signaling
inferredcites →https://doi.org/10.1128/jvi.00949-10openalex-snapshot
Chikungunya Virus Nonstructural Protein 2 Inhibits Type I/II Interferon-Stimulated JAK-STAT Signaling
inferredcites →https://doi.org/10.1128/jvi.01041-09openalex-snapshot
Venezuelan Equine Encephalitis Virus Disrupts STAT1 Signaling by Distinct Mechanisms Independent of Host Shutoff
inferredcites →https://doi.org/10.1128/jvi.01209-09openalex-snapshot
Similarities and Differences in Antagonism of Neuron Alpha/Beta Interferon Responses by Venezuelan Equine Encephalitis and Sindbis Alphaviruses
inferredcites →https://doi.org/10.1128/jvi.01282-07openalex-snapshot
Identification and Characterization of Interferon-Induced Proteins That Inhibit Alphavirus Replication
inferredcites →https://doi.org/10.1128/jvi.01441-10openalex-snapshot
Functional Sindbis Virus Replicative Complexes Are Formed at the Plasma Membrane
inferredcites →https://doi.org/10.1128/jvi.01540-09openalex-snapshot
Novel Functions of the Alphavirus Nonstructural Protein nsP3 C-Terminal Region
inferredcites →https://doi.org/10.1128/jvi.01785-06openalex-snapshot
Role of the Amphipathic Peptide of Semliki Forest Virus Replicase Protein nsP1 in Membrane Association and Virus Replication
inferredcites →https://doi.org/10.1128/jvi.01786-15openalex-snapshot
Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin
inferredcites →https://doi.org/10.1128/jvi.01852-17openalex-snapshot
Purification of Highly Active Alphavirus Replication Complexes Demonstrates Altered Fractionation of Multiple Cellular Membranes
inferredcites →https://doi.org/10.1128/jvi.02073-06openalex-snapshot
The Old World and New World Alphaviruses Use Different Virus-Specific Proteins for Induction of Transcriptional Shutoff
inferredcites →https://doi.org/10.1128/jvi.02411-06openalex-snapshot
Semliki Forest Virus Nonstructural Protein 2 Is Involved in Suppression of the Type I Interferon Response
inferredcites →https://doi.org/10.1128/jvi.02564-07openalex-snapshot
Recruitment of Antigen-Presenting Cells to the Site of Inoculation and Augmentation of Human Immunodeficiency Virus Type 1 DNA Vaccine Immunogenicity by In Vivo Electroporation
inferredcites →https://doi.org/10.1128/jvi.02603-09openalex-snapshot
Chikungunya Virus Arthritis in Adult Wild-Type Mice
inferredcites →https://doi.org/10.1128/jvi.03443-13openalex-snapshot
Interferon-Stimulated Poly(ADP-Ribose) Polymerases Are Potent Inhibitors of Cellular Translation and Virus Replication
showing the first 200 of 247 · page through all 247
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4742779openalex-extracted
A First-Principles Approach to Decode the Interferon Response to MRNA-Based Vaccines in Antigen Presenting Cells
inferred← citeshttps://doi.org/10.1016/j.addr.2022.114236openalex-snapshot
Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics
inferred← citeshttps://doi.org/10.1016/j.addr.2023.114961openalex-snapshot
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics
inferred← citeshttps://doi.org/10.1016/j.addr.2024.115305openalex-snapshot
A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines
inferred← citeshttps://doi.org/10.1016/j.ajps.2025.101090openalex-snapshot
The strategies and advances of mRNA translation booster
inferred← citeshttps://doi.org/10.1016/j.biotechadv.2024.108492openalex-snapshot
Current innovations in mRNA vaccines for targeting multidrug-resistant ESKAPE pathogens
inferred← citeshttps://doi.org/10.1016/j.clim.2024.110424openalex-snapshot
Clinical advancements in mRNA vaccines against viral infections
inferred← citeshttps://doi.org/10.1016/j.cmicom.2025.105081openalex-snapshot
Opportunities for rhinovirus-targeted RNA therapeutics: A narrative review
inferred← citeshttps://doi.org/10.1016/j.drudis.2022.103341openalex-snapshot
Self-amplifying mRNA vaccines: Mode of action, design, development and optimization
inferred← citeshttps://doi.org/10.1016/j.eclinm.2025.103428openalex-snapshot
Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (ARCT-2303), with or without co-administration of seasonal inactivated influenza vaccine in adults: a phase 3, randomised, controlled, observer-blind, multicentre study
inferred← citeshttps://doi.org/10.1016/j.intimp.2024.112320openalex-snapshot
mRNA vaccines against infectious diseases and future direction
inferred← citeshttps://doi.org/10.1016/j.omtn.2022.11.024openalex-snapshot
Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines
inferred← citeshttps://doi.org/10.1016/j.omtn.2023.102045openalex-snapshot
Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice
inferred← citeshttps://doi.org/10.1016/j.omtn.2024.102313openalex-snapshot
Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.5c00670openalex-snapshot
Recent Developments of RNA Vaccines and Therapeutics: Reagents, Formulations, and Characterization
inferred← citeshttps://doi.org/10.1039/d3cs00805copenalex-snapshot
Therapeutic synthetic and natural materials for immunoengineering
inferred← citeshttps://doi.org/10.1080/10717544.2025.2566782openalex-snapshot
Nucleic acid-encoded antibody gene transfer-next generation of antibody therapies
inferred← citeshttps://doi.org/10.1080/14760584.2024.2354251openalex-snapshot
Research progress on the quality control of mRNA vaccines
inferred← citeshttps://doi.org/10.1080/14760584.2024.2374287openalex-snapshot
Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers
inferred← citeshttps://doi.org/10.1080/14760584.2025.2487542openalex-snapshot
Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study
inferred← citeshttps://doi.org/10.1080/17460441.2022.2147501openalex-snapshot
Vaccines on demand, part II: future reality
inferred← citeshttps://doi.org/10.1080/21645515.2025.2530291openalex-snapshot
A second-generation, self-amplifying COVID-19 Vaccine: World’s first approval and distribution in the Japanese market with vaccine hesitancy
inferred← citeshttps://doi.org/10.1093/oxfimm/iqac004openalex-snapshot
Polymer formulated self-amplifying RNA vaccine is partially protective against influenza virus infection in ferrets
inferred← citeshttps://doi.org/10.1111/hiv.70024openalex-snapshot
mRNA vaccines against HIV : Hopes and challenges
inferred← citeshttps://doi.org/10.1155/jotm/6688914openalex-snapshot
From Outbreaks to Artificial Intelligence: A Comprehensive Review of Monkeypox Virus Epidemiology, Diagnosis, Treatment, Vaccination, and Deep Learning Applications
inferred← citeshttps://doi.org/10.1186/s12575-025-00269-2openalex-snapshot
Recent Advances in mRNA-Based Vaccines Against Several Hepatitis Viruses
inferred← citeshttps://doi.org/10.1186/s12929-022-00852-9openalex-snapshot
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
inferred← citeshttps://doi.org/10.1186/s12951-024-02355-1openalex-snapshot
RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
inferred← citeshttps://doi.org/10.1186/s40794-024-00222-3openalex-snapshot
A landscape review of malaria vaccine candidates in the pipeline
inferred← citeshttps://doi.org/10.20944/preprints202308.0245.v1openalex-snapshot
Recent Advances in mRNA Vaccine Development
inferred← citeshttps://doi.org/10.2169/naika.113.2049openalex-snapshot
I. Vaccine Modality and Immune Responses
inferred← citeshttps://doi.org/10.23880/oajmb-16000275openalex-snapshot
Recent Advances in mRNA Vaccine Development
inferred← citeshttps://doi.org/10.30574/wjbphs.2024.20.2.0911openalex-snapshot
Innovations in mRNA-based cancer immunotherapy: Challenges and future directions
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1261243openalex-snapshot
Amplifying mRNA vaccines: potential versatile magicians for oncotherapy
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1448489openalex-snapshot
Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy
inferred← citeshttps://doi.org/10.3389/fphar.2026.1852041openalex-snapshot
mRNA cancer vaccines: delivery strategies, immune modulation, and clinical translation
inferred← citeshttps://doi.org/10.3390/ijms232112884openalex-snapshot
Self-Amplifying RNA Approach for Protein Replacement Therapy
inferred← citeshttps://doi.org/10.3390/ijms252312883openalex-snapshot
MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products—A Prospective Analysis
inferred← citeshttps://doi.org/10.3390/vaccines12010061openalex-snapshot
Breaking Barriers: A Future Perspective on Glioblastoma Therapy with mRNA-Based Immunotherapies and Oncolytic Viruses
inferred← citeshttps://doi.org/10.3390/vaccines12101161openalex-snapshot
Modelling the Relative Vaccine Efficacy of ARCT-154, a Self-Amplifying mRNA COVID-19 Vaccine, versus BNT162b2 Using Immunogenicity Data
inferred← citeshttps://doi.org/10.3390/vaccines13020151openalex-snapshot
Q Fever Vaccines: Unveiling the Historical Journey and Contemporary Innovations in Vaccine Development
inferred← citeshttps://doi.org/10.3390/vaccines9090965openalex-snapshot
An Update on mRNA-Based Viral Vaccines
inferred← citeshttps://doi.org/10.5772/intechopen.108163openalex-snapshot
Prophylactic Ribonucleic Acid Vaccines to Combat RNA Viral Infections in Humans
inferred← citeshttps://doi.org/10.6084/m9.figshare.21085242openalex-snapshot
Additional file 1 of A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.